QureBio is a biotechnology company focused on developing bispecific and multispecific antibody and protein therapeutics to address unmet medical needs in cancer, autoimmune diseases, and inflammatory disorders. Utilizing proprietary technology platforms such as the I2T platform and T-cell and NK-cell engager platforms, QureBio is advancing a robust pipeline of novel drug candidates targeting previously intractable diseases.
Leadership & Board
Current Number of Employees2
Current LinkedIn Followers12
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$100M
Total Amount Raised$100M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$100M
Latest Funding Amount$100M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
QureBio had 2 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
2Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
QureBio had 12 followers as of September 14, 2026. The number of followers increased by 0 (0.00%) week-over-week.
12Latest Followers Count
0(0.00%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.